Inventor · disambiguated record
Peter Matthiessen
Also filed as: MATTHIESSEN PETER
18 granted patents·5 pending applications·134 citations·filing 1999–2024
94Inventor score
Top patents by PatentIndex Score
23 records- 0197US10758599B2Stabilized liquid and lyophilized ADAMTS13 formulationsBAXALTA INC·Filed 2019·Granted Sep 1, 2020·10 cites·28 claims
- 0294US11191837B2Recombinant VWF formulationsTAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Dec 7, 2021·9 cites·12 claims
- 0394US2025099559A1Stabilized liquid and lyophilized adamts13 formulationsTAKEDA PHARMACEUTICALS CO·Filed 2024·Application pending·0 cites
- 0491US10238720B2Stabilized liquid and lyophilized ADAMTS13 formulationsBAXALTA INC·Filed 2018·Granted Mar 26, 2019·5 cites·30 claims
- 0591US8623352B2Stabilized liquid and lyophilized ADAMTS13 formulationsMATTHIESSEN PETER·Filed 2010·Granted Jan 7, 2014·13 cites·50 claims
- 0689US9937244B2Stabilized liquid and lyophilized ADAMTS13 formulationsBAXALTA INC·Filed 2017·Granted Apr 10, 2018·4 cites·32 claims
- 0789US9572778B2Stabilized liquid and lyophilized ADAMTS13 formulationsBAXALTA INC·Filed 2016·Granted Feb 21, 2017·4 cites·54 claims
- 0887US12178861B2Stabilized liquid and lyophilized ADAMTS13 formulationsTAKEDA PHARMACEUTICALS CO·Filed 2022·Granted Dec 31, 2024·0 cites·20 claims
- 0985US8377375B2Methods for the inactivation of microorganisms in biological fluids, flow through reactors and methods of controlling the light sum dose to effectively inactivate microorganisms in batch reactorsBAXTER INT·Filed 2011·Granted Feb 19, 2013·7 cites·24 claims
- 1082US7993580B2Methods for the inactivation of microorganisms in biological fluids, flow through reactors and methods of controlling the light sum dose to effectively inactivate microorganisms in batch reactorsBAXTER INT·Filed 2004·Granted Aug 9, 2011·32 cites·23 claims
- 1182US7807435B2Method for the purification of alpha-1 proteinase inhibitor (a1PI)BAXTER INT·Filed 2005·Granted Oct 5, 2010·6 cites·14 claims
- 1276US11564979B2Stabilized liquid and lyophilized ADAMTS13 formulationsTAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Jan 31, 2023·0 cites·26 claims
- 1376US6777390B1Stable blood coagulation inhibitor-free factor vii preparation and method for preparing sameBAXTER AG·Filed 1999·Granted Aug 17, 2004·29 cites·27 claims
- 1470US2009192076A1Recombinant vwf formulationsBAXTER INT·Filed 2008·Application pending·0 cites
- 1567US9351935B2Stabilized liquid and lyophilized ADAMTS13 formulationsBAXTER INT·Filed 2013·Granted May 31, 2016·0 cites·29 claims
- 1664US9512172B2Ethanol dependence of alpha1 antitrypsin C-terminal Lys truncation by basic carboxypeptidasesBAXALTA INC·Filed 2014·Granted Dec 6, 2016·0 cites·19 claims
- 1759US8772240B2Ethanol dependence of alpha1 antitrypsin C-terminal lys truncation by basic carboxypeptidasesMATTHIESSEN PETER·Filed 2007·Granted Jul 8, 2014·0 cites·11 claims
- 1858US8343748B2Preparative purification process for human furinBAXTER INT·Filed 2008·Granted Jan 1, 2013·0 cites·13 claims
- 1956US2013119265A1Methods for the inactivation of mircroorganisms in biological fluids, flow through reactors and methods of controlling the light sum dose to effectively inactivate microorganisms in batch reactorsBAXTER INT·Filed 2013·Application pending·0 cites
- 2052US8986607B2Method for the validatable inactivation of pathogens in a biological fluid by irradiationANDERLE HEINZ·Filed 2004·Granted Mar 24, 2015·15 cites·30 claims
- 2145US2013115204A1Preparative purification process for human furinBAXTER INT·Filed 2012·Application pending·0 cites
- 2244US2003133829A1Process for inactivating pathogens in a biological materialBAXTER HEALTHCARE CORP·Filed 2001·Application pending·0 cites
- 2342US9388452B2Methods for modeling protein stabilityMATTHIESSEN PETER·Filed 2011·Granted Jul 12, 2016·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Peter Matthiessen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →